Showing results (111-120 of 203) with videos related to

Sort By:
Pageof 21
Virology|November 28, 2017
Establishment of robust HCV genotype 4d, 5a, and 6a replicon systemsGregory Camus, Simin Xu, Bin Han, et al.
Hepatology (Baltimore, Md.)|June 28, 2003
Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis BChristopher E Westland, Huiling Yang, William E Delaney, et al.
Biochemistry|February 3, 2005
Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activitiesCathryn A Shaw-Reid, Bradley Feuston, Vandna Munshi, et al.
Antiviral Therapy|October 25, 2017
Characterization of HCV resistance from a 3-day monotherapy study of voxilaprevir, a novel pangenotypic NS3/4A protease inhibitorEric Lawitz, Jenny C Yang, Luisa M Stamm, et al.
Antiviral Therapy|May 12, 2009
Mutations in the thumb-connection and RNase H domain of HIV type-1 reverse transcriptase of antiretroviral treatment-experienced patientsJoshua M Waters, Wesley O'Neal, Kirsten L White, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2005
Covalent stabilization of coiled coils of the HIV gp41 N region yields extremely potent and broad inhibitors of viral infectionElisabetta Bianchi, Marco Finotto, Paolo Ingallinella, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Characterization of resistance to the protease inhibitor GS-9451 in hepatitis C virus-infected patientsHadas Dvory-Sobol, Kelly A Wong, Karin S Ku, et al.
HIV Clinical Trials|October 29, 2014
Week 144 resistance analysis of elvitegravir/cobicistat/emtricitabine/tenofovir DF versus atazanavir+ritonavir+emtricitabine/tenofovir DF in antiretroviral-naïve patientsRima Kulkarni, Michael E Abram, Damian J McColl, et al.
Antimicrobial Agents and Chemotherapy|August 27, 2014
Clinical and in vitro resistance to GS-9669, a thumb site II nonnucleoside inhibitor of the hepatitis C virus NS5B polymeraseHadas Dvory-Sobol, Christian Voitenleitner, Eric Mabery, et al.
AIDS (London, England)|April 28, 2011
Clinical efficacy of raltegravir against B and non-B subtype HIV-1 in phase III clinical studiesJürgen K Rockstroh, Hedy Teppler, Jing Zhao, et al.
Pageof 21